Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 2
1955 1
1956 4
1957 5
1958 2
1959 3
1960 9
1961 4
1962 2
1963 2
1964 4
1965 1
1966 2
1967 3
1968 1
1969 5
1970 2
1971 8
1972 7
1973 3
1974 6
1975 4
1976 11
1977 11
1978 3
1979 1
1980 3
1981 9
1982 5
1983 5
1984 4
1985 10
1986 10
1987 6
1988 5
1989 4
1990 4
1991 3
1992 1
1993 3
1994 1
1995 7
1996 2
1997 1
1998 6
1999 3
2000 1
2002 2
2003 1
2004 3
2005 2
2006 11
2007 5
2008 4
2009 8
2010 5
2011 10
2012 9
2013 6
2014 8
2015 5
2016 3
2017 3
2018 8
2019 4
2020 6
2021 13
2022 11
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Blagoy
Page 1
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Castaigne S, Pautas C, Terré C, Raffoux E, Bordessoule D, Bastie JN, Legrand O, Thomas X, Turlure P, Reman O, de Revel T, Gastaud L, de Gunzburg N, Contentin N, Henry E, Marolleau JP, Aljijakli A, Rousselot P, Fenaux P, Preudhomme C, Chevret S, Dombret H; Acute Leukemia French Association. Castaigne S, et al. Lancet. 2012 Apr 21;379(9825):1508-16. doi: 10.1016/S0140-6736(12)60485-1. Epub 2012 Apr 5. Lancet. 2012. PMID: 22482940 Clinical Trial.
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.
Dumas PY, Raffoux E, Bérard E, Bertoli S, Hospital MA, Heiblig M, Desbrosses Y, Bonmati C, Pautas C, Lambert J, Orvain C, Banos A, Pasquier F, Peterlin P, Marchand T, Uzunov M, Frayfer J, Turlure P, Cluzeau T, Jourdan E, Himberlin C, Tavernier E, Villate A, Haiat S, Chretien ML, Carre M, Chantepie S, Vaida I, Wemeau M, Chebrek S, Guillerm G, Guièze R, Debarri H, Gehlkopf E, Laribi K, Marcais A, Santagostino A, Béné MC, Mineur A, Pigneux A, Dombret H, Récher C. Dumas PY, et al. Leukemia. 2023 Jan;37(1):91-101. doi: 10.1038/s41375-022-01742-7. Epub 2022 Nov 14. Leukemia. 2023. PMID: 36376378 Free article.
New Data on Cylindrospermopsin Toxicity.
Chichova M, Tasinov O, Shkodrova M, Mishonova M, Sazdova I, Ilieva B, Doncheva-Stoimenova D, Kiselova-Kaneva Y, Raikova N, Uzunov B, Ivanova D, Gagov H. Chichova M, et al. Toxins (Basel). 2021 Jan 8;13(1):41. doi: 10.3390/toxins13010041. Toxins (Basel). 2021. PMID: 33429940 Free PMC article.
CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.
Lacan C, Caron J, Tarantino N, Fouquet B, Cherai M, Parizot C, Morel V, Souchet L, Uzunov M, Gorochov G, Nguyen-Quoc S, Sourdeau E, Vieillard V, Miyara M, Vinit A, Solorzano S, Soussain C, Houillier C, Metz C, Autran B, Litvinova E, Le Garff-Tavernier M, Norol F, Roos-Weil D, Choquet S, Guihot A, Baron M. Lacan C, et al. Haematologica. 2023 Dec 1;108(12):3485-3490. doi: 10.3324/haematol.2023.282875. Haematologica. 2023. PMID: 37345469 Free PMC article. No abstract available.
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Marmouset V, Decroocq J, Garciaz S, Etienne G, Belhabri A, Bertoli S, Gastaud L, Simand C, Chantepie S, Uzunov M, Genthon A, Berthon C, Chiche E, Dumas PY, Vargaftig J, Salmeron G, Lemasle E, Tavernier E, Delage J, Loirat M, Morineau N, Blanc-Durand F, Pautier P, Vergé V, Auger N, Thomas M, Stefani L, Lepelley M, Boyer T, Thepot S, Gourin MP, Bourquard P, Duchmann M, Morice PM, Michallet M, Adès L, Fenaux P, Récher C, Dombret H, Pagès A, Marzac C, Leary A, Micol JB; UNIHEM, French Network of Pharmacovigilance Centers, ALFA, FILO, and GFM. Marmouset V, et al. Clin Cancer Res. 2022 Dec 1;28(23):5211-5220. doi: 10.1158/1078-0432.CCR-22-1622. Clin Cancer Res. 2022. PMID: 36201165
Review of Cyanotoxicity Studies Based on Cell Cultures.
Sazdova I, Keremidarska-Markova M, Chichova M, Uzunov B, Nikolaev G, Mladenov M, Schubert R, Stoyneva-Gärtner M, Gagov HS. Sazdova I, et al. J Toxicol. 2022 Apr 25;2022:5647178. doi: 10.1155/2022/5647178. eCollection 2022. J Toxicol. 2022. PMID: 35509523 Free PMC article. Review.
Neuroactive steroids and affective disorders.
Eser D, Schüle C, Baghai TC, Romeo E, Uzunov DP, Rupprecht R. Eser D, et al. Pharmacol Biochem Behav. 2006 Aug;84(4):656-66. doi: 10.1016/j.pbb.2006.05.020. Epub 2006 Jul 10. Pharmacol Biochem Behav. 2006. PMID: 16831459 Review.
328 results